| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/2008 | EP1880724A1 Liquid formulation comprising clozapine, quetiapine, a salt of quetiapine and/or olanzapine for oral administration |
| 01/23/2008 | EP1880723A1 Combination of mTOR inhibitor and antifolate compound |
| 01/23/2008 | EP1880722A1 Pharmaceutical compositions of ciprofloxacin |
| 01/23/2008 | EP1880721A1 Agent for improving circulatory disorder |
| 01/23/2008 | EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 01/23/2008 | EP1880719A2 Composition for prophylaxis or treatment of urinary system infection and method thereof |
| 01/23/2008 | EP1880716A1 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 01/23/2008 | EP1880715A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/23/2008 | EP1880714A1 Amorphous Aripiprazole and Process for the Preparation thereof |
| 01/23/2008 | EP1880213A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 01/23/2008 | EP1879905A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 01/23/2008 | EP1879904A1 4" amino linked macrolides useful for the treatment of microbial infections |
| 01/23/2008 | EP1879903A1 Ether linked macrolides useful for the treatment of microbial infections |
| 01/23/2008 | EP1879901A1 Pyrrolobenzodiazepines |
| 01/23/2008 | EP1879900A2 Sulfoximine-pyrimidine macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer |
| 01/23/2008 | EP1879898A2 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists |
| 01/23/2008 | EP1879897A1 Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(fish-r) antagonists |
| 01/23/2008 | EP1879896A1 Imidazopyridazine compounds |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1879894A1 Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 01/23/2008 | EP1879892A2 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 01/23/2008 | EP1879891A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity |
| 01/23/2008 | EP1879888A2 Crystalline forms of tiotropium bromide |
| 01/23/2008 | EP1879887A2 Npy antagonists, preparation and use |
| 01/23/2008 | EP1879885A1 Heterocyclic antiviral compounds |
| 01/23/2008 | EP1879884A1 Azole-based phosphodiesterase inhibitors |
| 01/23/2008 | EP1879883A2 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth |
| 01/23/2008 | EP1879882A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
| 01/23/2008 | EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 01/23/2008 | EP1879880A2 Dihydroxyphenylalanine derivatives |
| 01/23/2008 | EP1879879A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/23/2008 | EP1879877A2 Antimicrobial agents |
| 01/23/2008 | EP1879875A1 Crystal forms opf {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| 01/23/2008 | EP1879874A2 Process for preparing quetiapine and quetiapine fumarate |
| 01/23/2008 | EP1879870A1 Antitumoral tetrahydro-pyrimidines |
| 01/23/2008 | EP1879866A1 Dihydropyridine derivatives |
| 01/23/2008 | EP1879865A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/23/2008 | EP1879864A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 01/23/2008 | EP1879862A2 Magnesium salts of hmg-coa reductase inhibitors |
| 01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 01/23/2008 | EP1879859A2 Diarylsulfone sulfonamides and use therof |
| 01/23/2008 | EP1879856A2 Alkyl-, alkenyl- and alkynyl carbamate derivatives, the preparation and therapeutic use thereof |
| 01/23/2008 | EP1879855A2 Trpv1 agonist compounds and methods for making and using the same |
| 01/23/2008 | EP1879854A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
| 01/23/2008 | EP1879853A1 Pregabalin free of isobutylglutaric acid and a process for preparation thereof |
| 01/23/2008 | EP1879852A1 Pregabalin free of lactam and a process for preparation thereof |
| 01/23/2008 | EP1879657A2 Use of compounds to enhance processivity of telomerase |
| 01/23/2008 | EP1879656A1 Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879655A2 Pharmaceutical composition comprising an anti-bacterial agent and an activeingredient selected from carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879654A2 Pharmaceutical combination comprenant un agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol and alpha-and beta-ionones |
| 01/23/2008 | EP1879621A2 Active composition for treatment or prevention of problems related to a disturbance of the biological clock |
| 01/23/2008 | EP1879619A2 Analgesic combination of sodium channel blockers with opioid antagonists |
| 01/23/2008 | EP1879608A1 Method for fostering bone formation and preservation |
| 01/23/2008 | EP1879598A1 Adjuvant comprising oligonucleotide and non toxic lps |
| 01/23/2008 | EP1879597A2 Lipid a analogs for treating oral and gastrointestinal mucositis |
| 01/23/2008 | EP1879596A1 20-alkyl, gemini vitamin d3 compounds and methods of use thereof |
| 01/23/2008 | EP1879595A2 Compositions and methods for treating hyperproliferative epidermal diseases |
| 01/23/2008 | EP1879594A2 Use of a combination of vitamins b and phytosterols for lowering blood pressure |
| 01/23/2008 | EP1879593A2 Low dose administration of a topical composition |
| 01/23/2008 | EP1879592A1 Use of inhibitors of steroid (testosterone) activity (i.a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 01/23/2008 | EP1879591A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders |
| 01/23/2008 | EP1879590A1 Eslicarbazepine acetate and methods of use |
| 01/23/2008 | EP1879589A2 Treatment and control of severe infections including cystic fibrosis |
| 01/23/2008 | EP1879588A2 Combination therapy |
| 01/23/2008 | EP1879587A2 Methods and compositions for treating or preventing cancer |
| 01/23/2008 | EP1879586A1 Nutritional preparations comprising folates and essential fatty acids |
| 01/23/2008 | EP1879585A1 Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 01/23/2008 | EP1879584A1 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome |
| 01/23/2008 | EP1879583A2 Quinine formulations |
| 01/23/2008 | EP1879582A2 Combination of dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity |
| 01/23/2008 | EP1879581A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| 01/23/2008 | EP1879580A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 01/23/2008 | EP1879579A1 Inhalation device containing plural doses of a pharmaceutical composition |
| 01/23/2008 | EP1879578A2 Methods and compositions for the treatment of urinary incontinence |
| 01/23/2008 | EP1879577A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| 01/23/2008 | EP1879576A1 Use of a metal ion chelating agent for the treatment of animal and human parasites |
| 01/23/2008 | EP1879575A2 Thiazole compounds and methods of use |
| 01/23/2008 | EP1879574A2 Multimediator 5-ht6 receptor antagonists, and uses related thereto |
| 01/23/2008 | EP1879573A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 01/23/2008 | EP1879572A2 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 01/23/2008 | EP1879571A1 Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent |
| 01/23/2008 | EP1879569A2 Therapeutic combinations for the treatment or prevention of psychotic disorders |
| 01/23/2008 | EP1879568A1 Stable pharmaceutical compositions of platinum (ii) antitumour agents |
| 01/23/2008 | EP1879567A1 Amino acid derivatives |
| 01/23/2008 | EP1879566A1 Compositions and methods for inhibiting gastric acid secretion |
| 01/23/2008 | EP1879565A2 Topical pharmaceutical formulation containing nimesulide |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1879563A2 Novel chemical compounds |
| 01/23/2008 | EP1879562A2 Phenol derivatives and their use to modulate pkb activity |
| 01/23/2008 | EP1879561A2 Novel use of liver x receptor agonists |
| 01/23/2008 | EP1879560A2 Solid transdermal therapeutic system comprising uv absorber |
| 01/23/2008 | EP1879559A2 Oral medicament based on a proton pump inhibitors |
| 01/23/2008 | EP1879557A1 Morphine sulfate formulations |
| 01/23/2008 | EP1879555A2 Dosage form with improved release of cefuroximaxetil |
| 01/23/2008 | EP1879465A1 Composition comprising peptide |
| 01/23/2008 | EP1879456A2 Pharmaceutical compositions with synchronized solubilizer release |
| 01/23/2008 | EP1879449A2 Compositions and methods for skin care |
| 01/23/2008 | EP1835904A4 Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin c derivatives |
| 01/23/2008 | EP1799679B1 N,n'-dithenylurea derivatives suitable as kinase inhibitors |
| 01/23/2008 | EP1732898B1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors |